Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Lauren

Sanctions on Russian investor funding has limited impact on foreign innovator drugs, says GlobalData

The West’s sanctions on Russia, as well as biopharmaceutical companies and venture investment firms halting investment and business with Russian companies, will impact only a few early-stage innovator drugs that involve Russian investors as venture financing from Russian investors in foreign innovator drugs is limited, says GlobalData, a leading data and analytics company. Sharon Cartic, […]
Read more
,

Amazon’s job postings for Project Kuiper and Freight nearly doubled in Q1 2022 indicating expansion, finds GlobalData

Amazon’s job postings for Project Kuiper (to launch low Earth orbit satellites) and Freight have nearly doubled from 580 in Q1 2021 compared to 1018 in Q1 2022, observes GlobalData, a leading data and analytics company. Sherla Sriprada, Business Fundamentals Analyst at GlobalData, comments: “From groceries, to healthcare, to satellites, Amazon has been expanding its platform […]
Read more

Big data will play a major role in the pharma value chain as it helps deliver efficiency improvements, says GlobalData

Exploiting big data analytics via emerging technologies such as artificial intelligence (AI) and Internet of Things (IoT) has improved return on investment in the pharma industry by shortening drug development timelines, reducing costs, increasing sales, and improving the likelihood of drug approval. If this continues, big data will transform the pharmaceutical industry in the coming […]
Read more
, ,

Crypto firms continue to clash with governments over regulations, says GlobalData

In response to the news that crypto business leaders are objecting to EU proposals to regulate cryptocurrencies, including requiring crypto firms to disclose transaction details; Amrit Dhami, Associate Analyst in the Thematic Research team at GlobalData, comments: “Anonymity is big within the world of cryptocurrency, from the anonymous crypto wallets to the creative pseudonyms of […]
Read more

Sotagliflozin significantly reduces risk of cardiovascular death in patients with both T2D and CKD, says GlobalData

At the 71st annual American College of Cardiology (ACC) 2022 meeting, results presented for the SCORED trial will likely lead to a large market share for Lexicon Pharmaceuticals’ sodium-glucose co-transporter-inhibitor (SGLT-I) sotagliflozin (Zynquista). The therapy is currently in Phase III in the US, as physicians increasingly prescribe SGLT-2Is for patients with Type 2 Diabetes (T2D) […]
Read more

Augmented reality will soon become a gamechanger in the energy sector as it brings significant cost and time savings, says GlobalData

As augmented reality (AR) technology continues to improve, it will become a gamechanger for utilities companies, bringing them significant cost and time savings.  As a result of this, it continues to be a source of investment for companies in the energy and utilities sector, says GlobalData. The leading data and analytics company notes that AR […]
Read more

Eco badges will grow in importance for tourism industry as travelers seek increased transparency, says GlobalData

Many travelers now require higher levels of transparency from companies in terms of their environmental performance, with GlobalData’s poll* finding that almost 75% of global consumers agreed that the introduction of sustainability labels on products should be mandatory. The leading data and analytics company notes that these badges help tourism companies to boost transparency, offer […]
Read more
,

Elon Musk buying Twitter would increase its commercialization potential, but raise misinformation concerns, says GlobalData

Following the news that Elon Musk has offered to buy Twitter for a total of $43.4 billion, analysts from GlobalData’s Thematic Research team offer their view; Daniel Clarke, Thematic Analyst at GlobalData, comments: “The offer to buy Twitter outright reflects Elon Musk’s distaste for orthodox board bureaucracy and what he sees as unnecessary regulatory hurdles. […]
Read more

Finland seeks large UAV fleet as Europe rearms due to Russia-Ukraine conflict, says GlobalData

Following the news that the Finnish Defence Forces (FDF) are seeking to spend around €14 million on a large fleet of unmanned aerial vehicles (UAVs) due to the Russia-Ukraine conflict; James Marques, Associate Aerospace, Defence and Security Analyst at GlobalData, a leading data and analytics company, offers his view: “Finland intends to acquire anywhere from […]
Read more
,

Global deal activity mostly remained flat in Q1 2022 compared to the same period last year, finds GlobalData

An analysis of GlobalData’s Financial Deals Database revealed that a total of 17,745 deals* were announced globally during Q1 2022, according to GlobalData. The leading data and analytics company found that this is a marginal increase of 0.8% over the 17,601 deals that were announced during Q1 2021. However, deal activity showcased a month-on-month fluctuating trend in […]
Read more

Sykes Cottages acquisition of Forest Holidays puts it in a strong position to cash in on UK domestic tourism boom, says GlobalData

After acquiring yet another UK holiday firm in Forest Holidays, Sykes Cottages has positioned itself well to capitalize on the booming staycation market in the UK, observes GlobalData. The leading data and analytics company’s projections show that the UK should expect approximately 123 million overnight domestic trips this year. This statistic is a 23% Year-on-Year […]
Read more
,

Deal activity in travel and tourism sector improved by 1.8% in Q1 2022 compared to Q1 2021, finds GlobalData

A total of 289 deals* were announced in the global travel and tourism sector during Q1 2022, according to GlobalData, a leading data and analytics company. An analysis of the company’s Financial Deals Database reveals that this is a growth of 1.8% compared to the 284 deals that were announced in Q1 2021. Aurojyoti Bose, Lead Analyst […]
Read more

BridgeBio’s acoramidis positioned to directly compete against Pfizer’s Vyndaqel for treatment of ATTR-CM if it passes trials, says GlobalData

BridgeBio’s acoramidis, an orally administered small molecule transthyretin, is currently being assessed in Phase II and Phase III trials and if it passes, it will be fighting against Pfizer’s Vyndaqel (tafamidis) for a share of the transthyretin amyloidosis cardiomyopathy (ATTR-CM) and ATTR-polyneuropathy (ATTR-PN) market, observes GlobalData, the leading data and analytics company. Samisha Khangaonkar, Pharma […]
Read more

Russia’s suspension from the Human Rights Council may impede bilateral ties, says GlobalData

Following the news that the UN has suspended Russia from the Human Rights Council; Gargi Rao, Economic Research Analyst at GlobalData, a leading data and analytics company, offers her view: “Russia’s suspension from the Human Rights Council has triggered other economies to impose even stronger sanctions on Russian manufacturers, oligarchs, and financial institutions thereby jeopardising […]
Read more
,

Prolonged Russia-Ukraine conflict could further affect automotive production in Russia, says GlobalData

The ongoing Russia-Ukraine crisis has already caused supply disruptions at certain auto manufacturing plants in Russia. The prolonged conflict could lead to even more supply constraints and subsequent delays in automotive production and shipments, finds GlobalData, the leading data and analytics company. A contraction in sales in Russia in particular, but also now spreading to […]
Read more

Combination of recent and anticipated therapy approvals expected to widen interest in the age-related macular degeneration market, says GlobalData

A flourish of activity in the wet age-related macular degeneration (wAMD) market, coupled with anticipated approvals of other products—particularly biosimilars—is expected to widen interest in the AMD market among stakeholders, says GlobalData, a leading data and analytics company. Vinie Varkey, Pharmaceutical Analyst at GlobalData, comments: “The wAMD market is on the precipice of a wave of new products. GlobalData’s Pharmaceutical Intelligence […]
Read more

Inflationary pressures from Russia-Ukraine crisis will cause Eastern European construction output to fall by 3.4% in 2022, finds GlobalData

As a result of the Russia-Ukraine crisis, the construction industry in Eastern Europe is expected to shrink by 3.4% in 2022 due to rising inflation and weak investor confidence, says GlobalData, a leading data and analytics company. Joel Hanna, Economist at GlobalData, comments: “Construction in most countries in Eastern Europe is likely to be affected by […]
Read more
1 … 14 15 16 17 18 … 23